Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.
van Leeuwen LPM, Grobben M, GeurtsvanKessel CH, Ellerbroek PM, de Bree GJ, Potjewijd J, Rutgers A, Jolink H, van de Veerdonk FL, van Gils MJ, de Vries RD, Dalm VASH; VACOPID Research Group. van Leeuwen LPM, et al. Among authors: van de veerdonk fl. Front Immunol. 2024 Apr 18;15:1390022. doi: 10.3389/fimmu.2024.1390022. eCollection 2024. Front Immunol. 2024. PMID: 38698851 Free PMC article.
Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo.
Koch RM, Kox M, Thijs EJM, Rahamat-Langendoen JC, van de Veerdonk FL, Gerretsen J, Schloesser J, Diavatopoulos D, Rimmelzwaan GF, Netea MG, van der Hoeven JG, de Jonge MI, Pickkers P. Koch RM, et al. Among authors: van de veerdonk fl, de jonge mi, van der hoeven jg. Front Immunol. 2017 Dec 11;8:1600. doi: 10.3389/fimmu.2017.01600. eCollection 2017. Front Immunol. 2017. PMID: 29312282 Free PMC article.
Increased Plasma Heparanase Activity in COVID-19 Patients.
Buijsers B, Yanginlar C, de Nooijer A, Grondman I, Maciej-Hulme ML, Jonkman I, Janssen NAF, Rother N, de Graaf M, Pickkers P, Kox M, Joosten LAB, Nijenhuis T, Netea MG, Hilbrands L, van de Veerdonk FL, Duivenvoorden R, de Mast Q, van der Vlag J. Buijsers B, et al. Among authors: van de veerdonk fl, de nooijer a, de mast q, van der vlag j, de graaf m. Front Immunol. 2020 Oct 6;11:575047. doi: 10.3389/fimmu.2020.575047. eCollection 2020. Front Immunol. 2020. PMID: 33123154 Free PMC article.
Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL, van Daele PLA, Simons A, Heijstek M, Beck DB, Netea MG, van Paassen P, Elizabeth Hak A, van der Veken LT, van Gijn ME, Hoischen A, van de Veerdonk FL, Leavis HL, Rutgers A. van der Made CI, et al. Among authors: van de veerdonk fl, de sevaux rgl, van paassen p, van gijn me, van der veken lt, van daele pla. J Allergy Clin Immunol. 2022 Jan;149(1):432-439.e4. doi: 10.1016/j.jaci.2021.05.014. Epub 2021 May 25. J Allergy Clin Immunol. 2022. PMID: 34048852
Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19.
Solanich X, Vargas-Parra G, van der Made CI, Simons A, Schuurs-Hoeijmakers J, Antolí A, Del Valle J, Rocamora-Blanch G, Setién F, Esteller M, van Reijmersdal SV, Riera-Mestre A, Sabater-Riera J, Capellá G, van de Veerdonk FL, van der Hoven B, Corbella X, Hoischen A, Lázaro C. Solanich X, et al. Among authors: van reijmersdal sv, van de veerdonk fl, van der hoven b, van der made ci. Front Immunol. 2021 Jul 23;12:719115. doi: 10.3389/fimmu.2021.719115. eCollection 2021. Front Immunol. 2021. PMID: 34367187 Free PMC article. Clinical Trial.
Stimulating severe COVID-19: the potential role of GM-CSF antagonism.
Leavis HL, van de Veerdonk FL, Murthy S. Leavis HL, et al. Among authors: van de veerdonk fl. Lancet Respir Med. 2022 Mar;10(3):223-224. doi: 10.1016/S2213-2600(21)00539-7. Epub 2021 Dec 1. Lancet Respir Med. 2022. PMID: 34863335 Free PMC article. No abstract available.
Natural resistance against infections: focus on COVID-19.
Netea MG, Domínguez-Andrés J, van de Veerdonk FL, van Crevel R, Pulendran B, van der Meer JWM. Netea MG, et al. Among authors: van de veerdonk fl, van der meer jwm, van crevel r. Trends Immunol. 2022 Feb;43(2):106-116. doi: 10.1016/j.it.2021.12.001. Epub 2021 Dec 7. Trends Immunol. 2022. PMID: 34924297 Free PMC article. Review.
Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic Centers.
Elsink K, Huibers MMH, Hollink IHIM, Simons A, Zonneveld-Huijssoon E, van der Veken LT, Leavis HL, Henriet SSV, van Deuren M, van de Veerdonk FL, Potjewijd J, Berghuis D, Dalm VASH, Vermont CL, van de Ven AAJM, Lambeck AJA, Abbott KM, van Hagen PM, de Bree GJ, Kuijpers TW, Frederix GWJ, van Gijn ME, van Montfrans JM; Genetics First for Primary Immunodeficiency Disorders Consortium. Elsink K, et al. Among authors: van de veerdonk fl, van hagen pm, van de ven aajm, van gijn me, van der veken lt, de bree gj, van montfrans jm, van deuren m. Front Immunol. 2021 Dec 21;12:780134. doi: 10.3389/fimmu.2021.780134. eCollection 2021. Front Immunol. 2021. PMID: 34992599 Free PMC article.
A guide to immunotherapy for COVID-19.
van de Veerdonk FL, Giamarellos-Bourboulis E, Pickkers P, Derde L, Leavis H, van Crevel R, Engel JJ, Wiersinga WJ, Vlaar APJ, Shankar-Hari M, van der Poll T, Bonten M, Angus DC, van der Meer JWM, Netea MG. van de Veerdonk FL, et al. Among authors: van der meer jwm, van der poll t, van crevel r. Nat Med. 2022 Jan;28(1):39-50. doi: 10.1038/s41591-021-01643-9. Epub 2022 Jan 21. Nat Med. 2022. PMID: 35064248 Review.
295 results